Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:14:22 EDT Sat 09 Aug 2025
Enter Symbol
or Name
USA
CA



Q:FBIO - FORTRESS BIOTECH INC - https://fortressbiotech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FBIO - Q4.11.81·2.000.11.82-0.03-1.6115.31905141.87  1.87  1.812.36  1.32516:10:04Aug 0715 min RT 2¢

Recent Trades - Last 10 of 514
Time ETExPriceChangeVolume
16:10:04Q1.82-0.031
16:04:08Q1.82-0.031
16:04:00Q1.82-0.031
16:00:01Q1.82-0.03100
16:00:01Q1.82-0.03139
16:00:01Q1.82-0.035
16:00:01Q1.82-0.03202
16:00:00Q1.82-0.0380
15:59:51Q1.83-0.024
15:59:50Q1.83-0.02200

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-08-07 08:30U:FBIONews ReleaseJourney Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
2025-08-05 16:01U:FBIONews ReleaseJourney Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
2025-07-14 08:30U:FBIONews ReleaseJourney Medical Corporation Announces Expanded Payer Coverage for Emrosi(TM)
2025-07-07 08:31U:FBIONews ReleaseMustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
2025-06-24 08:30U:FBIONews ReleaseJourney Medical to Join Russell 2000(TM) and Russell 3000(TM) Indexes
2025-06-20 08:31U:FBIONews ReleaseJourney Medical Corporation Announces Emrosi(TM) Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
2025-06-09 08:30U:FBIONews ReleaseJourney Medical Corporation Announces Emrosi(TM) Featured on "The Balancing Act" Airing on Lifetime TV
2025-05-30 10:48U:FBIONews ReleaseFortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
2025-05-15 16:05U:FBIONews ReleaseFortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-14 16:02U:FBIONews ReleaseJourney Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-13 16:16U:FBIONews ReleaseCheckpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
2025-05-07 16:01U:FBIONews ReleaseJourney Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
2025-05-07 08:00U:FBIONews ReleaseFortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
2025-04-01 16:01U:FBIONews ReleaseJourney Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
2025-03-31 16:05U:FBIONews ReleaseFortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
2025-03-28 08:30U:FBIONews ReleaseCheckpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
2025-03-26 16:01U:FBIONews ReleaseJourney Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
2025-03-24 08:30U:FBIONews ReleaseJourney Medical Corporation Launches Emrosi(TM) (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
2025-03-19 16:02U:FBIONews ReleaseJourney Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025
2025-03-17 08:56U:FBIONews ReleasePartex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform